Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01651806Phase 3Completed
Phase 3, randomised, double-blind trial of tranexamic acid in intraoperative bleeding (5 arms), sponsored by Rush University Medical Center. Primary endpoints: Primary Intra-operative Blood Loss and Incidences of DVT and Other Thromboembolic Events at 1 year. Started May 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01651806.